Get the E-newsletter
rising costs and the increasing emphasis on delivering high-quality
care at a reasonable price, healthcare organizations require effective
processes for assessing the value of drugs and healthcare services. In this
edition of the Healthcare Challenge Roundtable, senior provider and health plan
leaders examine best practices for gauging value.
are Jimmy Chung, MD, senior director
of perioperative services, Providence Health & Services, Seattle; Michael Sherman, MD, senior vice
president and chief medical officer, Harvard Pilgrim Health Care, Boston; and Barbara Strain, director of value
management, University of Virginia Health System, Charlottesville, Va.
What are the most
important questions and criteria to consider when weighing the value of a
healthcare service, device, or drug?
Jimmy Chung: First,
we should define what we mean by value.
When talking about healthcare services, devices, or drugs, value is quality and outcomes divided by cost or margin. The most
important aspect of this definition is the outcomes piece because that’s what
the patient sees and experiences. Since patients are the primary customers in
health care, we must focus on what matters to them—their clinical results,
perceptions, and experiences, as well as the safety and accessibility of the
drugs or services.
that when determining whether something delivers positive patient outcomes,
organizations should double-check that what they define as a positive outcome is
aligned with the patient’s definition. Perhaps an individual wants to walk
again or live long enough to attend his or her granddaughter’s wedding; to the
individual, that’s a positive result. At Providence Health & Services, we aim
to partner with patients to decide what we’re going to look for when reviewing a
drug or service’s potential and how we’re going to ensure that the evidence
shows the product or drug has been able to meet those criteria.
Barbara Strain: There
is often a misconception that healthcare providers are being asked to use the
cheapest drug or product to save money. However, assessing value involves much
more than seeking a strong financial return on investment. At University of
Virginia, we consider the whole value proposition. This process includes
examining everything from patient outcomes to patient safety, staff safety,
diversity of services, and throughput across the continuum of care.
with any research project, when measuring value, you must first define the
problem you’re trying to solve or the goal you’re trying to reach. For example,
does the product allow you to move a test or procedure from an inpatient
setting to an outpatient setting? Does it help improve efficiency? Is it going
to drive quality? Improve financial viability? Enhance the patient experience? We
have adopted a Lean approach to assessing value, where we clearly define the
problem we’re trying to address and systematically review viable options to see
how we can best meet our goals. Value=Quality/Costs,
which proves true in any circumstance. The more
organizations focus on improving quality, the more they will find that costs fall
away and value improves.
are some of the most common pitfalls in assessing value?
potential pitfall emerges when the information you are reviewing is not
up-to-date. Perhaps a study was conducted years ago and is not as relevant now,
or maybe it applies only to certain demographics that don’t align with your
patients. You want to make sure that you have strong resources to support
assessment—whether internal or external—so you can be confident that you fully
understand the benefits and how they relate to your patients.
often have physicians or other subject-matter experts give presentations on
specific products, drugs, or services. This permits more back-and-forth
discussion that can ensure all questions are addressed while preventing key
points from getting lost in translation.
Michael Sherman: With
greater attention being paid to not just efficacy but cost as well, there is a
growing need for research and expert recommendations that can demonstrate the
value of a product or service from the perspective of various stakeholders,
including the patient, provider, manufacturer, and payer. As an industry, we
are in the early innings of assessing value, and while there are a number of approaches
that attack different aspects of the question, they do not necessarily come
at Harvard Pilgrim Health Care are especially cognizant of the fact that much
clinical research is done under the best possible circumstances—well-constructed
clinical trials conducted by investigators who are experts in their fields and
see a large number of patients with a specific condition. New drugs most often
are tested against a placebo, and each study participant is followed very
closely by a clinical research associate. Unfortunately, that is just not how
care is delivered in the real world. Patients may not understand instructions;
they may be taking multiple medications; or physicians may be rushed and not
fully explain how to properly use a drug or device.
reality is that mileage does vary outside of the clinical trial environment. So,
while well-conducted research studies are certainly necessary, they are only
one indicator of value. For that reason, approaches that assess value based on real-world
experience are highly beneficial.
theory, we would look at double-blind randomized trials with a large sample
size, but that’s not always possible or even the best choice. The research also
must be reproducible and relevant. For instance, if you’re researching a new
implant and it shows less inflammation in rats, that doesn’t necessarily
translate into better results for people.
other thing is that we don’t always have studies available, and so sometimes
the best option is a consensus among experts. This may take the form of
frameworks, collaborative white papers, and so on. There’s even been some use
of social media among physicians to collect feedback, although I wouldn’t
condone that on a wide scale. There’s work being done now to validate the
quality improvement that can be achieved using social media.
challenge is that the cost of a drug accrues to the payer immediately, whereas
the drug or service may not yield full value for years or even decades. In
these cases, one may need to substitute process measures as proxies for
long-term outcomes. But with that approach, the cause and effect need to be
Another pitfall occurs when provider organizations focus only on unit cost
reduction without considering the total cost of the episode. Hospitals may see savings
when they look at per case cost reduction for a particular surgery, but they
may be blind to the costs that are incurred outside the hospital walls.
Medicare data show that the majority of care costs for a hip replacement surgery,
for example, are incurred in the postoperative period after patients leave the
acute setting. As hospitals and health systems start participating in more
bundled payment models, if they don’t look at what the total cost of the
episode is going to be, they probably won’t truly save or reduce healthcare
costs in the end.
key lesson here is to look outside the hospital when judging value and try to be
as patient-centric as possible.
What are the keys to
ensuring value-assessment approaches don’t become too provider- or
payer-focused and overlook patients?
it is important to understand the value to both payer and provider, we need to
always put the patient at the center. While economics are important, ultimately
the metrics that we choose to measure and reward through outcomes-based agreements
should be the ones that matter to the patient.
would also emphasize that assessment frameworks are merely one tool for making
a treatment decision and that patient input is essential every step of the way.
For example, some frameworks allow for weighting and prioritization of various
attributes, such as willingness to accept the risk of various adverse events.
By ensuring that these weightings reflect the preferences of a specific
patient, we can ensure that these approaches are applicable to individual
circumstances and are not “cookie-cutter.”
we always come back to is, “What’s the best thing for the patient?” Something
may cost several thousand dollars more, but if it’s the right thing for the
patient, we need to consider it.
see this in both the operative and procedural environments. Let’s say we’ve
been doing a standard procedure over the years because there was no other way
to do it. Now robotics or minimally invasive devices are available, and they
are more expensive, but the patient has a much better experience. You must keep
an open mind to these opportunities. You also should look down the road and
consider how many readmissions or other clinical conditions will be avoided if you
make the shift.
bottom line is you should view the whole continuum because in the current healthcare
environment, we must keep patients out of the hospital, shift more procedures
to the outpatient setting, and then make sure that if people still need to come
to the hospital, the experience is as rewarding as possible and leads to the
patients have poor outcomes, it costs more for all stakeholders—the patients, hospitals,
payers, and so on. So by focusing on how to improve patient outcomes, everyone
this requires thinking outside the box. For instance, an idea that is gaining traction
is the perioperative surgical home. This is a model for providing seamless,
coordinated care from the moment a decision for surgery is made to the
postoperative point where the intended outcomes are met. To encourage positive results,
there is substantial upfront work in the form of preoperative assessments. The
patient care team is basically prehabilitating the patient from a nutrition, physical
ability, and mental health standpoint to put him or her in the best position to
successfully tolerate and recover from the surgery.
none of this proactive care has been reimbursed, and nobody has done it unless
surgeons decided to do some of it in their own office—but few surgeons have
opted for this approach. However, if surgeons, hospitals, physician practices, patients,
and payers come together and agree that these things are important to make sure
that the patient has a good outcome, then everybody will benefit in the end.
This is a patient-centered approach, and although it may seem like it’s going
to cost more because you have to dedicate resources—a preoperative clinic and
staff, for example—evidence will show that these patients will have better
outcomes, which will lower the overall cost of care.
In your experience, how
effective do frameworks developed by associations, such as the Institute for Clinical and Economic Review, tend
are so early in the value-assessment life cycle that there is not a lot of
objective data about the impact of these frameworks. To get a better sense of
their true usefulness, we will need to see greater utilization, and that will
take time. That said, they do provide objective information that—along with
other types of evidence—may be viewed by a pharmacy and therapeutics (P&T)
committee in coming to a decision, and they have the potential to drive a more
robust discussion than might otherwise occur.
chair my organization’s P&T committee and would note that the pharmacists
and physicians who serve on it actively welcome information about value to
inform specific decisions. That awareness and interest seems to be increasing.
I have also heard colleagues at professional meetings express concern when
there is slow adoption of drugs shown by ICER to be fairly priced, which
further speaks to the growing impact of models such as ICER’s.
would stress however that value frameworks are only one of many data points
that inform P&T decisions. For instance, in choosing between which of two
self-administered injectable medications to prefer, the committee will not only
review evidence including value assessments but may also pass around the
injection devices and consider feedback from patient advocacy groups as to
which one is easier to use.
assessments have long been used in some other countries to inform what drugs
and other therapies will be available. If a potential drug doesn’t meet a
stated value threshold, it might not be covered. In response, the manufacturer
has the option of adjusting the price to meet the value threshold in order to
qualify for coverage. These approaches force stakeholders to engage in hard discussions
about the value of a life, which is a subject we have avoided in the United
States. So, while value-assessment frameworks are extraordinarily helpful, it
is important to understand that there is not an arbitrary value beyond which a
drug will not be covered.
What is the appropriate
scope of value measurement for a healthcare organization? For example, should
it be done at the individual patient level, the department level, the
organizational level, a larger population level, or a combination?
is a combination. You may look at the individual patient level, but then you
telescope out to the larger patient population. Let’s say you see 3,000
patients with a particular condition. You can affect each of those patients in
a certain way. Then you must consider how this impacts the service line, the
organization, or the population in your community.
contemplating these diverse perspectives, you need someone who is trained to
understand all the levels of decision making. In addition, you must bring
various stakeholders to the table—clinicians, administrators, patients—so you
can systematically go through an approach that will get you to the correct
I think it can be done at all levels, but they serve different purposes—and ultimately
the value to the individual should dictate all the other metrics. Face it, you
can’t define the value of a service for an organization without first
understanding the value of that care for the patient. Otherwise, an
organization may end up pushing its own agenda.
instance, if an organization is considering a robot program because it has the
potential to bring in more surgical cases, improve market share, elevate the organization’s
reputation, and provide greater access, those are organizational goals. You
can’t start there and then push that value onto the patient because then you’re
incentivized to create or perform surgeries that may not necessarily have tremendous
benefit for the individual. Let’s say you’re looking to use the robot program
for hernia repair. From the patient’s standpoint, he or she has a hernia and it
needs to be addressed. The individual wants the best way to fix that quickly
and inexpensively without having to take off too much time from work.
Considering the evidence, the best option is probably a quick outpatient
surgery with a small incision under local anesthetic, resulting in minimal patient
pain and a rapid return to work. The robot program—while cool—does not markedly
improve things for the patient.
these situations, it’s up to us as healthcare leaders to portray an honest
assessment of the value to patients because they may not know. They may do
research online and see a lot of ads from hospitals that say, “We have a robot
to fix your hernia and our outcomes are great.” They will also notice
testimonials from patients that say, “I was able to go back to work the next
day and I didn’t take any medications.” This is marketing—not research or
evidence. We as physicians, scientists, and patient advocates should refocus
our attention on what truly brings value to patients and not superimpose our
other intentions onto them.
done well, how can value assessment promote innovation in health care?
physicians are always seeking ways to innovate. A strong review process allows
you to understand and embrace the risks of innovation so you can realize the
potential benefits. We can’t be afraid of new opportunities, but we must also
exercise caution when implementing them and must rely on data.
after you start using a product, drug, or service, you should continue to
collect information. It’s important to first establish a baseline—whether that’s
length of stay, cost, quality of life, treatment safety, or whatever criteria
can accurately reflect your decision. You must agree on that baseline ahead of
time and decide on the source that will show variation from the
baseline. After a period of time, if you’re not meeting your anticipated goals,
you need to be committed to assessing why the product, drug, or treatment
didn’t provide the desired outcome. In some cases, you may even need to remove
it from use. This may require going back through the whole cycle of improvement
and determining what your goals are and whether they’re being met.
to my initial definition of value as quality
and outcomes over cost or margin, those four variables represent distinct
opportunities for innovation. We are at the beginning of the value-assessment
journey, and the process will surely evolve over time. As we improve, the potential
for innovation is great, provided organizations keep patients at the center.
is an HFMA contributing writer and editor.
Interviewed for this
Chung, MD, senior director of perioperative services,
Providence Health & Services, Seattle; Michael Sherman,
MD, senior vice president and chief medical officer, Harvard Pilgrim Health
Care, Boston; Barbara
Strain, director of value management, University of Virginia
Health System, Charlottesville, Va.
Check out previous installments of the
Healthcare Challenge Roundtable:
Working Together to Make Alternative
Payment Models Succeed
Change Healthcare: Accelerating Revenue Cycle Transformation
Jason Williams, vice president for strategy and business analytics, Change Healthcare, discusses the importance of technology and technology-enabled services in reinventing the revenue cycle.
Ensemble Health Partners: Driving Revenue Cycle Innovation
Judson Ivy, president of Ensemble Health Partners, discusses the value of revenue cycle outsourcing and the importance of selecting the right partner.
Grant Thornton: Facilitating EAM
Priority Advantage: Helping Organizations Optimize Their Medicare Advantage Plans
6 Patient Revenue Cycle Metrics You Should Be Tracking (and How to Improve Your Results)
Patient financial engagement is more challenging than ever – and more critical. With patient responsibility as a percentage of revenue on the rise, providers have seen their billing-related costs and accounts receivable levels increase. If increasing collection yield and reducing costs are a priority for your organization, the metrics outlined in this presentation will provide the framework you need to understand what’s working and what’s not, in order to guide your overall patient financial engagement initiatives and optimize results.
10 Ways to Reduce Patient Statement Volume (and Reduce Costs)
No two patients are the same. Each has a very personal healthcare experience, and each has distinct financial needs and preferences that have an impact on how, when and if they chose to pay their healthcare bill. It’s no longer effective to apply static billing techniques to solve the complex challenge of collecting balances from patients. The need to tailor financial conversations and payment options to individual needs and preferences is critical. This presentation provides 10 recommendations that will not only help you improve payment performance through a more tailored approach, but take control of rising collection costs.
Reduce Patient Balances Sent to Collection Agencies: Approaching New Problems with New Approaches
This white paper, written by Apex Vice President of Solutions and Services, Carrie Romandine, discusses the importance of patient segmentation and messaging specifically related to the patient revenue cycle. Applying strategic messaging that is tailored to each patient type will not only better educate consumers on payment options specific to their billing needs, but it will maximize the amount collected before sending to collections. Further, targeted messaging should be applied across all points of patient interaction (i.e. point of service, customer service, patient statements) and analyzed regularly for maximized results.
The Future of Online Patient Billing Portals
This white paper, written by Apex President Patrick Maurer, discusses methods to increase patient adoption of online payments. Providers are now seeking ways to incrementally collect more payments due from patients as well as speeding up the rate of collections. This white paper shows why patient-centric approaches to online payment portals are important complements to traditional provider-centric approaches.
Payment Portals Can Improve Self-Pay Collections and Support Meaningful Use
Increased electronic engagement between healthcare providers and patients provides significant opportunities for improving revenue cycle metrics and encouraging patients to access EHRs. This article, written by Apex Founder and CEO Brian Kueppers, explores a number of strategies to create synergy between patient billing, online payment portals and electronic health record (EHR) software to realize a high ROI in speed to payment, patient satisfaction and portal adoption for meaningful use.
Large Health System Drives 10% UP (Patient Payments) and 10% DOWN (Billing-related Costs)
Faced with a rising tide of bad debt, a large Southeastern healthcare system was seeing a sharp decline in net patient revenues. The need to improve collections was dire. By integrating critical tools and processes, the health system was able to increase online payments and improve its financial position. Taking a holistic approach increased overall collection yield by 10% while costs came down because the number of statements sent to patients fell by 10%, which equated to a $1.3M annualized improvement in patient cash over a six-month period. This case study explains how.
ICD-10: Managing Performance
With the ICD10 deadline quickly approaching and daily responsibilities not slowing down, final preparations for October 1 require strategic prioritization and laser focus.
Clarity Drives Collections
Read how Gwinnett Medical Center provides clear connections to financial information, offers multiple payment options for patients, and gives onsite staff the ability to collect payments at multiple points throughout the care process.
Orlando Health Gains Insight into Denials, Reduces A/R Days with RelayAnalytics Acuity
Read how Orlando Health was able to perform deeper dives into claims data to help the health system see claim rejections more quickly–even on the front end–and reduce A/R days.
Revenue Cycle Payment Clarity
To maintain fiscal fitness and boost patient satisfaction and loyalty, healthcare providers need visibility into when and how much they will be paid–by whom–and the ability to better navigate obstacles to payment. They need payment clarity. This whitepaper illuminates this concept that is winning fans at forward-thinking hospitals.
Streamlining the Patient Billing Process
Financial services staff are always looking for ways to improve the verification, billing and collections processes, and Munson Healthcare is no different. Read about how they streamlined the billing process to produce cleaner bills on the front end and helped financial services staff collect more than $1 million in additional upfront annual revenue in one year.
Wallace Thomson Hospital Automates to Maximize Limited Resources
Effective revenue cycle management can be a challenge for any hospital, but for smaller providers it is even tougher. Read how Wallace Thomson identified unreimbursed procedures, streamlined claims management, and improved its ability to determine charity eligibility.
7 Steps for Building and Funding Sustainability Projects
Before launching an energy-efficiency initiative, it’s important to build a solid business case and understand the funding options and potential incentives that are available. Healthcare leaders should consider taking the steps outlined in the whitepaper to ease the process of gaining approval, piloting, implementing, and supporting sustainability projects. You will find that investing in sustainability and energy efficiency helps hospitals add cash to their bottom line. Discover how hospitals and health systems have various options for funding energy-efficient and renewable-energy initiatives, depending on their current financial structure and strategy.
Key Capital Considerations for Mergers and Acquisitions
Health care is a dynamic mergers and acquisitions market with numerous hospitals and health systems contemplating or pursuing formal arrangements with other entities. These relationships often pose a strategic benefit, such as enhancing competencies across the continuum, facilitating economies of scale, or giving the participants a competitive advantage in a crowded market. Underpinning any profitable acquisition is a robust capital planning strategy that ensures an organization reserves sufficient funds and efficiently onboards partners that advance the enterprise mission and values.
Key Capital Considerations for Mergers and Acquisitions
The success of healthcare mergers, acquisitions, and other affiliations is predicated in part on available capital, and the need for and sources of funding are considerations present throughout the partnering process, from choosing a partner to evaluating an arrangement’s capital needs to selecting an integration model to finding the right money source to finance the deal. This whitepaper offers several strategies that health system leaders have used to assess and manage capital needs for their growing networks.
Trend Watch: Providers adapt as value-based care moves from hype to reality
Announcements from several commercial payers and the Centers for Medicare and Medicaid Services (CMS) early in 2015 around increased efforts to form value-based contracts with providers seemed to point to an impending rise in risk-based contracting. Rather than wait for disruption from the outside in, health care providers are now making inroads on collaborating with payers on various risk-based contracting models to increase the value of health care from within.
Yuma Regional Medical Center case study
Yuma Regional Medical Center (YRMC) is a not-for-profit hospital serving a population of roughly 200,000 in Yuma and the surrounding communities.
Before becoming a ZirMed client, Yuma was attempting to manually monitor hundreds of thousands of charges which led to significant charge capture leakage. Learn how Yuma & ZirMed worked together to address underlying collections issues at the front end, thus increasing Yuma’s overall bottom line.
Reforming with a New 50-Bed Acute Care Facility
Kindred Hospital Rehabilitation Services works with partners to audit the market and the facility’s role in that market to identify opportunities for improvement. This approach leads to successes; Kindred’s clinical rehab and management expertise complements our partners’ strengths. Every facility and challenge is unique, and requires a full objective analysis.
5-Minute Briefing on Revenue Integrity Through HIM WhitePaper Hospitals FS
As the critical link between patient care and reimbursement, health information enables more complete and accurate revenue capture. This 5-Minute White Paper Briefing shares how to achieve cost-effective revenue integrity by your optimizing HIM systems.
5-Minute Briefing on Accelerating Cash Flow Through HIM WhitePaper Hospitals FS
Speedier cash flow starts with better CDI and coding. This 5-Minute White Paper Briefing explains how providers can improve vital measures of technical and business performance to accelerate cash flow.
5-Minute Briefing on Reducing the Cost of RCM WhitePaper Hospitals FS
Qualified coders are getting harder to come by, and even the most seasoned professional can struggle with the complexity of ICD-10. This 5-Minute White Paper Briefing explains how partnerships can help improve coding and other key RCM operations potentially at a cost savings.
Providers Focus Too Much On Revenue Cycle Management
The point of managing your revenue cycle isn’t just to improve revenue and cash flow. It’s to do those things effectively by consistently following best practices— while spending as little time, money, and energy on them as possible.
Lucille Packard Children’s Hospital Stanford Case Study
How Lucile Packard Children’s Hospital Stanford increased payments received within 45 days by 20% and reduced paper submission claims by 70% by using ZirMed solutions.
Using Predictive Modeling To Detect Meaningful Correlations Across Claims Denials Data
The reasons claims are denied are so varied that managing denials can feel like chasing a thousand different tails. This situation is not surprising given that a hypothetical denial rate of just 5 percent translates to tens of thousands of denied claims per year for large hospitals—where real‐world denial rates often range from 12 to 22 percent. Read about how predictive modeling can detect meaningful correlations across claims denials data.
ZOLL and Emergency Mobile Health Care Case Study
Emergency Mobile Health Care (EMHC) was founded to be and remains an exclusively locally owned and operated emergency medical service organization; today EMHC serves a population of more than a million people in and around Memphis, answering 75,000 calls each year.
Maximizing Medicare Reimbursements White Paper
Since the Physician Quality Reporting Initiative (PQRI) introduction, CMS has paid more than $100 million in bonus payments to participants. However, these bonuses ended in 2015; providers who successfully meet the reporting requirements in 2016 will avoid the 2% negative payment adjustment in 2018, so now is the time to act! Included in this whitepaper are implications of increasing patient responsibility, collections best practices, and collections and internal control solutions.
Denials Deconstructed: Getting Your Claims Paid
Getting paid what your physician deserves—that’s the goal of every biller. Yet even for the best billers, achieving that success can be elusive when denials stand in the way of success, presenting challenges at every turn. Denials aren’t going away, but you can learn techniques to manage and even prevent them.Join practice management expert Elizabeth W. Woodcock, MBA, FACMPE, CPC, to: Discover methods to translate denial data into business intelligence to improve your bottom line, determine staff productivity benchmarks for billers, and recognize common mistakes in denial management.
Automation and Operational Improvement Drive Sustainable Results
Physician practices must improve organizational efficiency to compete in this era of reduced reimbursement and escalating administrative costs.
Revenue Cycle Management Resolves Migration Implementation Issues
Many healthcare organizations are pursuing next-generation health information systems solutions. Learn more about Navigant's work with University of Michigan Health System.
Partnering For Success – Provider Achieves Strength in Stability
The proper implementation of healthcare information technology systems is crucial to an organization’s financial health.
Building a Clinically-Integrated Network
As value-based payment models evolve, providers are challenged to maintain superior clinical outcomes while controlling costs.
Winning in the Post-Acute Marketplace
Read more about factors contributing to the changes in the post-acute marketplace and what it means for manufacturers, physicians, clinicians, patients, and post-acute facilities as they anticipate the transition to the second curve.
Building A Common Vision with Employed Physicians
HSG helped the physicians and executives of St. Claire Regional in Morehead, Kentucky, define their shared vision for how the group would evolve over the next decade. As well as, develop the strategic and operational priorities which refocused and accelerated the group’s evolution.
Practice Performance Improvement
The client was a nine-hospital health system with 14 clinics serving communities in a multi-state market with very limited access to care, poor economic conditions, high unemployment, and a heavy Medicare/Medicaid/uninsured payer mix. In most of these communities, the system was the sole source of care.
Though the clinics were of substantial size (they employed 98 physicians) and comprised of multiple specialists, the physicians functioned as individuals and the practices lacked any real group culture.
Clinical Integration Without Spending a Fortune
Clinical integration can be expensive, but it doesn’t have to be, as this four-step road map for developing a CIN proves. Does it have to cost millions to initiate a clinical integration strategy?
Contrary to popular belief, we have clients who have generated substantial shared savings and a significant ROI over time, without massive investments. Yes, some financial capital is required for resources the CIN providers can’t bring to the table themselves. But the size of that investment can be miniscule relative to the value it produces: improved outcomes and documentation for payers.
Adding Value to Physician Compensation
Today’s concerns about physician compensation are the result of the changing healthcare environment. The transition to value is slow, but finally becoming a reality. Proactive hospitals want to ensure that provider incentives are properly aligned with ever-increasing value-based demands.
This report focuses on the three big questions HSG receives about adding value to physician compensation; Why are organizations redesigning their provider compensation plans? What elements and parameters must be part of successful compensation plans? How are organizations implementing compensation changes?
Effective Revenue Cycle Management in Your Network
Revenue Cycle Management has become an even more complex issue with declining reimbursements, implementation of Electronic Health Records, evolving local carrier determinations (LCD), and payer credentialing [The emphasis on healthcare fraud, abuse and compliance has increased the importance of accuracy of data reporting and claims filing).
The efficiency of a medical practice’s billing operations has critical impact on the financial performance. In many cases, patient billings are the primary revenue source that pays staff salaries, provider compensation and overhead operating cost. Inefficiencies or inaccurate billing will contribute to operating losses.
Succeeding in Value-Based Care
This publication identifies and outlines the necessary characteristics of a fully-functioning clinically integrated network (CIN). What it doesn’t do is detail how hospitals and providers can participate in the value-based care environment during the development process.
One common misconception is that the CIN can’t do anything significant until it has obtained the FTC’s “clinically integrated” stamp of approval. While the network must satisfy the FTC’s definition of clinical integration before single signature contracting for FFS rates and contracts can legally start, hospitals and providers can enjoy three key benefits during the development process.
Therapy: Benefits at All Levels of Care
Nearly half of all Medicare beneficiaries treated in the hospital will need post-acute care services after discharge. For these patients, a stay in an inpatient rehabilitation facility, skilled nursing facility or other post-acute care setting comes between hospital and home.
Does Your Budgeting Process Lack Accountability?
With the proper process, tools, and feedback mechanisms in place, budgeting can be a valuable exercise for organizations while helping hold organizational leaders accountable. Having a proper monthly variance review process is one of the most critical factors in creating a more efficient and accurate budget. Monthly variance reporting puts parameters around what is to be expected during the upcoming budget entry process.
Cost Accounting: the Key to Cost Management and Profitability
Managing the cost of patient care is the top strategic priority of most hospital CFOs today. As healthcare shifts to more data-driven decision making, having clear visibility into key volume, cost and profitability measures across clinical service lines is becoming increasingly important for both long-range and tactical planning activities. In turn, the cost accounting function in healthcare provider organizations is becoming an increasingly important and strategic function. This whitepaper includes five strategies for efficient and accurate cost accounting and service line analytics and keys to overcoming the associated challenges.